(Q36140718)

English

Methylthioninium chloride: pharmacology and clinical applications with special emphasis on nitric oxide mediated vasodilatory shock during cardiopulmonary bypass

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

1 reference

Europe PubMed Central

Methylthioninium chloride: pharmacology and clinical applications with special emphasis on nitric oxide mediated vasodilatory shock during cardiopulmonary bypass (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

1 reference

based on heuristic

inferred from title

author name string

Faber P

1

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Ronald A

2

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Millar BW

3

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

language of work or name

0 references

publication date

1 June 2005

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

60

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

575-587

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Endogenous nitric oxide and low systemic vascular resistance after cardiopulmonary bypass.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

The inflammatory response to cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Pharmacokinetics of Highly Ionized Drugs II: Methylene Blue—Absorption, Metabolism, and Excretion in Man and Dog after Oral Administration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Pharmacokinetics and organ distribution of intravenous and oral methylene blue.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Pharmacokinetics of highly ionized drugs. I. Methylene blue--whole blood, urine, and tissue assays.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Angiotensin-converting enzyme inhibitors predispose to hypotension refractory to norepinephrine but responsive to methylene blue

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Administration of methylene blue in human septic shock: renaissance of an old drug?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Methylene blue as drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Methylene blue administration in septic shock: a clinical trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Methylene blue during cardiopulmonary bypass to treat refractory hypotension in septic endocarditis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Methylene blue for ifosfamide-associated encephalopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Effect of methylene blue on refractory neonatal hypotension.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

The methylene-blue baby

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Inhibition of nitric oxide synthesis by methylene blue.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Soluble guanylate cyclase purified from bovine lung contains heme and copper

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Methylene blue but not changes in cyclic GMP inhibits resting and bradykinin-stimulated production of prostacyclin by pig aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Inflammatory response to cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Nitric oxide and cyclic GMP signaling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Inhaled nitric oxide: basic biology and clinical applications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Localization of nitric oxide synthase indicating a neural role for nitric oxide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Septic shock: pathogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

The nitric oxide and cGMP signal transduction system: regulation and mechanism of action

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Regulation of cGMP-specific phosphodiesterase (PDE5) phosphorylation in smooth muscle cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Phosphodiesterase type 5 inhibition ameliorates nephrotoxicity induced by cyclosporin A in spontaneous hypertensive rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

The discovery of nitric oxide in the vessel wall. A unifying concept in the pathogenesis of sepsis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Effects of nitroglycerin at therapeutic doses on platelet aggregation in unstable angina pectoris and acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Ca2+/calmodulin-regulated nitric oxide synthases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Endothelium-dependent inhibition of platelet aggregation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Nitric oxide enhances PGI(2)production by human pulmonary artery smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

New developments on thromboxane and prostacyclin modulators part II: prostacyclin modulators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Impaired synthesis and action of antiaggregating cyclic nucleotides in platelets from obese subjects: possible role in platelet hyperactivation in obesity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Methylene blue for neutralization of heparin.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Heparin neutralization with methylene blue, hexadimethrine, or vancomycin after cardiopulmonary bypass.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Methylene blue does not neutralize heparin after cardiopulmonary bypass.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Continuously infused methylene blue modulates the early cardiopulmonary response to endotoxin in awake sheep

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Methylene blue reduces lung fluid filtration during the early phase of endotoxemia in awake sheep

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Methylene blue reverses endotoxin-induced hypotension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Inhibition of nitric oxide synthesis causes myocardial ischemia in endotoxemic rats.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Methylene blue increases myocardial function in septic shock

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Inhibition of nitric oxide synthesis in septic shock: how much is beneficial?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Methylene Blue Infusion in Septic Shock

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: a mechanism for stabilizing neutrophil adhesion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Ferritin binds to light chain of human H-kininogen and inhibits kallikrein-mediated bradykinin release

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

iNOS-mediated nitric oxide production and its regulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Activation of inflammatory systems during cardiopulmonary bypass.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

The role of neutrophils in myocardial ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Inflammatory response after myocardial revascularization with or without cardiopulmonary bypass.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Inter-individual differences in cytokine release in patients undergoing cardiac surgery with cardiopulmonary bypass.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Tumor Necrosis Factor Gene Polymorphism Is Associated with Enhanced Systemic Inflammatory Response and Increased Cardiopulmonary Morbidity After Cardiac Surgery

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Cytokine responses to cardiopulmonary bypass: lessons learned from cardiac transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Impact of left ventricular dysfunction on cytokines, hemodynamics, and outcome in bypass grafting.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Endotoxemia in coronary artery bypass surgery: A comparison of the off-pump technique and conventional cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Interleukin-1, interleukin-6 and myocardial enzyme response after coronary artery bypass grafting - a prospective randomized comparison of the conventional and three minimally invasive surgical techniques.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Lipopolysaccharide activates Akt in vascular smooth muscle cells resulting in induction of inducible nitric oxide synthase through nuclear factor-kappa B activation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Nitric oxide synthase induction, cGMP elevation, and biopterin synthesis in vascular smooth muscle cells stimulated with interleukin-1beta in hypoxia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Inhibition of lipopolysaccharide-induced inducible nitric oxide synthase expression by a novel compound, mercaptopyrazine, through suppression of nuclear factor-kappaB binding to DNA.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

How does peripheral lipopolysaccharide induce gene expression in the brain of rats?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Vasoplegic syndrome after off-pump coronary artery bypass surgery.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology, and clinical importance.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Risk factors and outcomes for 'vasoplegia syndrome' following cardiac transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Vasopressin therapy for vasoplegic syndrome following cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Methylene blue for lithium-induced refractory hypotension in off-pump coronary artery bypass graft: report of two cases.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Inhibition of Heparin/Protamine Complex-Induced Complement Activation by Compstatin in Baboons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04185.X

21 January 2018

Identifiers

10.1111/J.1365-2044.2005.04185.X

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36140718&oldid=1991127538"